The largest database of trusted experimental protocols

26 protocols using pyromark q48

1

Bisulfite-Based DNA Methylation Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA was extracted from 25 mg of snap frozen liver using the QIAmp mini kit (QIAGEN, Hilden, Germany). Genomic DNA was bisulphite-converted (bisDNA) using the EpiTectFast Bisulfite kit (QIAGEN). Bisulphite PCR was performed with the PyroMark PCR kit (QIAGEN). One primer pair was used to analyse CpG sites 1–5, a second primer pair was used to analyse CpG site 6 and a third pair was used for analysis of cg25924746 (see ESM Table 2 for a list of primers, including primer for rs4547213). DNA methylation was measured by bisulphite pyrosequencing using PyroMark Q48 and PyroMark Q48 Advanced reagents (QIAGEN) (see ESM Methods).
+ Open protocol
+ Expand
2

Quantifying DMPK Gene Methylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used bisulfite pyrosequencing to quantify the degree of DNA methylation at eight CpG sites upstream and six CpG sites downstream of the CTG repeat in the 3′ UTR region of the DMPK gene (Figure 1). These regions were chosen as previous studies had associated the methylation of these sites with the age at disease onset [4 (link),19 (link)] and the clinical phenotype [20 (link)]. Bisulfite conversion was carried out on 200 ng of DNA with an EZ-DNA Methylation-Gold kit (Zymo Research, Irvin, CA, USA), according to the manufacturer’s instructions, with an elution volume of 10 μL. Methylated and non-methylated standards and a no template control (NTC) were included with every conversion. PCR was performed with a Pyromark PCR kit (Qiagen, Hilden, Germany), using 1 μL of bisulfite-converted DNA. The PCR primers were designed with PyroMark Assay Design 2.0 (Qiagen) and were targeted to the regions flanking the CTG repeat (Figure 1). The PCR products were visualized on an agarose gel, and the methylation levels were quantified using a Pyromark Q48 Autoprep (Qiagen) and the Pyromark Q48 software (Qiagen). The primer sequences, modifications to the manufacturer’s instructions, and PCR conditions can be found in Table S1.
+ Open protocol
+ Expand
3

Pyrosequencing of FOXL2 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PyroMark PCR Kit (Qiagen, Hilden, Germany) was used for pyrosequencing with a forward primer (Pyro‐FOXL2‐F: 5′‐AGAAGGGCTGGCAAAATAGCATC‐3′) and reverse biotinylated primer (Pyro‐FOXL2‐R: 5′‐CCGGAAGGGCCTCTTCAT‐3′), or a reverse primer (Pyro‐FOXL2‐R2: 5′‐TAGTTGCCCTTCTCGAACATGTC‐3′) and a forward biotinylated primer (Pyro‐FOXL2‐F2: 5′‐CATCGCGAAGTTCCCGTTCTA‐3′). The PCR products were purified using streptavidin Sepharose HP beads (GE Healthcare, Buckinghamshire, UK), followed by hybridization with the sequencing primers (FOXL2‐seqF: 5′‐CGCAAGGGCAACTACT‐3′ or FOXL2‐seqR2: 5′‐CCTTCTCGAACATGTCT‐3′), as described in the PyroMark Q48 vacuum workstation guide (Qiagen). The sequencing data were analyzed using PyroMark Q48 software (Qiagen). The Pyrosequencing was performed and analyzed by Macrogen, Inc.
+ Open protocol
+ Expand
4

Pyrosequencing Analysis of FOXL2 Gene

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PyroMark PCR Kit (Qiagen, Hilden, Germany) was used for pyrosequencing with a forward primer (Pyro-FOXL2-F: 5′-AGAAGGGCTGGCAAAATAGCATC-3′) and reverse biotinylated primer (Pyro-FOXL2-R: 5′-CCGGAAGGGCCTCTTCAT-3′), or a reverse primer (Pyro-FOXL2-R2: 5′-TAGTTGCCCTTCTCGAACATGTC-3′) and a forward biotinylated primer (Pyro-FOXL2-F2: 5′-CATCGCGAAGTTCCCGTTCTA-3′). The PCR products were purified using streptavidin
Sepharose HP beads (GE Healthcare, Buckinghamshire, UK), followed by hybridization with the sequencing primers (FOXL2-seqF: 5′-CGCAAGGGCAACTACT-3′ or FOXL2-seqR2: 5′-CCTTCTCGAACATGTCT-3′), as described in the PyroMark Q48 vacuum workstation guide (Qiagen). The sequencing data were analyzed using PyroMark Q48 software (Qiagen). The
Pyrosequencing was performed and analyzed by Macrogen, Inc.
+ Open protocol
+ Expand
5

Quantitative Paralogous Amplification-Pyrosequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Quantitative paralogous amplification-pyrosequencing was carried out based on the published method [55 (link)]. This method takes advantage of the existence of identical sequences on chromosome 21 and one other autosome, allowing amplification of both loci with a single primer pair. Paralogous sequence mismatches in amplified products from chromosome 21 (GABPA and ITSN) can be quantified relative to their paralogous regions on chromosome 7 and 5, respectively. As such, trisomic cells show a 60:40 ratio for the paralogous sequence, whereas disomic cells produce a 50:50 ratio. Primers used for amplification and pyrosequencing are listed in Supplementary Table 5. Pyrosequencing was performed on the Pyromark Q48 machine (Qiagen) following standard procedures.
+ Open protocol
+ Expand
6

Wolbachia infection typing via pyrosequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols

Wolbachia infection types were checked in NONY, and DNA samples from a recently (July 2018) collected wild-type CAR262L strain using allele-specific pyrosequencing. Pyro PCR and sequencing primers were designed to target SNP positions in coxA and gatB genes (supplementary table S3, Supplementary Material online) in A1, A2, and B Wolbachia using PyroMark Assay Design 2.0 (Qiagen, USA). The A/G SNP targeted in coxA can separate B-Wolbachia from A1/A2-Wolbachia, and the C/T SNP in gatB allowed us to distinguish A1-Wolbachia from A2/B-Wolbachia. Pyrosequencing was performed on a Pyromark Q48 instrument (Qiagen, USA) using Pyromark Q48 Advanced Reagents (Qiagen, USA). Three technical replicates were performed for each sample.
+ Open protocol
+ Expand
7

DNA methylation analysis by pyrosequencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA methylation was analysed by pyrosequencing using the Pyromark Q48 (Qiagen) according to manufacturer’s guidelines. Briefly, bisulfite conversion was performed on 1 μg DNA using the EpiTect Fast Bisulfite Conversion Kit (Qiagen). Briefly, 140 μl bisulfite reactions were prepared with 20 μl DNA, 85 μl bisulfite solution and 35 μl DNA protect buffer (Thermo Fisher Scientific). Cycling conditions were as follows: 95°C for 5 min, 60°C for 20 min, 95°C for 5 min and 60°C for 20 min. Primers for methylation analysis were designed by the Pyromark Q48 Advanced Software (Supplementary Table S2 is available at Carcinogenesis Online) and DNA methylation analysis was then performed on the PyroMark after PCR amplification.
+ Open protocol
+ Expand
8

Validating Methylation Differences in GDM

Check if the same lab product or an alternative is used in the 5 most similar protocols
We sought to validate a few selected DMPs with relatively larger methylation differences between GDM and control groups in the epigenome wide association analysis. The study subjects were an independent random sample of 47 pairs of GDM and controls from the Shanghai Birth Cohort. 4 DMPs (CpG sites) were chosen as the corresponding delta betas were in the top 30 DMPs and the corresponding genes have been related to glucose homeostasis (30 (link), 31 (link)). These CpG sites were annotated to WSC Domain Containing 2 (WSCD2), phosphodiesterase 1C (PDE1C), and protocadherin Beta 15 (PCDHB15). DNA was sodium-bisulfite treated (EZ DNA Methylation-Lighting) and PCR-amplified with primers designed by PyroMark Assay Design software (version 2.0; Qiagen). Pyrosequencing was performed using PyroMark Q48 (Qiagen, appendix –Methodology in the pyrosequencing study).
+ Open protocol
+ Expand
9

Bisulfite Sequencing of Genomic DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 500 ng of genomic DNA was used for bisulfite conversion using an EZ DNA Methylation-Gold Kit (Zymo Research, Irvine, CA, USA). Bisulfite sequencing primers for the different genes were designed using PyroMark assay design software (Qiagen Inc., Hilden, Germany). Because of its influence on the transcription of the gene, the assays prioritized the study of the promoter region. The details for the primer sequences are summarized in Table 1. PCRs were carried out for each gene in a total volume of 25µL. Methylation was determined by pyrosequencing on a PyroMark Q48 (Qiagen Inc., Hilden, Germany). The results were analyzed by PyroMark Q48 Autoprep 2.4.2. Software (Qiagen Inc., Hilden, Germany).
+ Open protocol
+ Expand
10

Pyrosequencing Validation of Placental-Cord Methylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The top differentially methylated CpGs shared between the placenta and umbilical cord (annotating for HADHA and SLC2A8 genes) were selected for validation in 90 paired placenta and umbilical cord samples by pyrosequencing bisulfite-treated DNA. Genomic DNA was isolated from placenta and umbilical cord samples using the QIAamp DNA mini kit (Qiagen, Hilden, Germany). Sodium bisulfite conversion of 500 ng of DNA was performed using the EpiTect Fast DNA Bisulfite Kit (Qiagen). Bisulfite-treated DNA (10 ng) was PCR-amplified with 2 μM of forward and biotinylated reverse primers (Supplementary Table S1). Both PCR and sequencing primers were designed with the usage of PyroMark Assay Design 2.0 software (Qiagen). The PCR product was rendered single-stranded through biotin capture on magnetic beads and then annealed to the sequencing primer (4 mM) to be subsequently pyro-sequenced in PyroMark Q48 Instrument (Qiagen). CpG site methylation was quantified with the PyroMark Q48 (Qiagen). Raw data were analyzed using the PyroMark Q48 AutoPREP Software V2.4.2 (Qiagen) and the percentage of methylation for each analyzed CpG was obtained.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!